Approval · Notice of Compliance 6229 · 2005
OXILAN: Notice of Compliance 6229
Issued January 31, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6229
- Date
- January 31, 2005
- Company
- GuerbetRoissy Cdg Cedex, Val-D'Oise, France
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Nonionic contrast agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OXILAN | 02264595 | — |
| OXILAN | 02264587 | — |